Efforts to Improve Health Care Affordability in Massachusetts

“Health care is just too challenging and costly for many individuals,” remarked Mr. Healey, emphasizing his focus on affordability as he campaigns for re-election this November. “We’re implementing some of the most comprehensive actions in the country to ensure people can get the care they need more quickly, affordably, and easily.”

In addition, Mr. Healey introduced a new working group dedicated to health care affordability, which will pull together leaders from various sectors including business, health care, insurance, and labor.

This announcement comes shortly after Mr. Healey’s previous health-related initiative, which he labeled as “leading the nation.” Just last week, he revealed a $250 million state trust fund aimed at assisting Massachusetts residents facing rising premiums from the Affordable Care Act marketplace.

These changes were announced as Mr. Healey and Democrats ramp up re-election efforts, positioning themselves as champions of affordability for constituents. Mr. Healey made similar promises during his campaign four years ago but has intensified his focus on the issue through measures like the trust fund, a tax cut he signed in 2023, and significant housing legislation, all while defending against Republican challengers concerned about the high cost of living in the state.

The new Affordable Care Working Group will be headed by Kate Walsh, a former Secretary of Health and Human Services and past CEO of Boston Medical Center, alongside Citizens Bank Massachusetts President Lisa Murray.

Recent insurance regulations aim to eliminate prior authorization requirements for several types of care, including emergency and urgent services, primary care, and some prescription medications. Currently, clinics often face hurdles in getting reimbursed for certain services due to prior authorization demands, with response times varying significantly among insurers. Blue Cross Blue Shield of Massachusetts, the largest insurance provider in the state, averages a 1 to 2 day wait for emergency requests, claiming that about 85% of decisions are made within 10 days.

The new rules will mandatorily require insurers to respond to emergency requests within 24 hours and guarantee that patient treatment is uninterrupted during insurance plan changes.

This policy applies to all insurance companies operating in Massachusetts, though it doesn’t cover “self-insured” employers who, being the majority in the commercial market, manage their health benefits directly. This means large employers might still impose prior approval requirements despite the new restrictions.

For some patients, this shift could be significant. State officials noted that individuals with diabetes will no longer need prior approval to access essential supplies and treatments related to their condition.

However, for others, the impact may be less pronounced. These new regulations build upon commitments many insurance companies have already made regarding prior authorization practices.

For instance, Blue Cross Blue Shield of Massachusetts does not currently require prior authorization for inpatient acute care, urgent care, or primary care. Additionally, back in June, a coalition of insurers, including Blue Cross Blue Shield and Point32 Health, committed to reforming prior authorization protocols, ensuring that if a patient changes insurance during treatment, their current prior authorizations for in-network services will be honored for 90 days instead of requiring immediate new approvals.

These new regulations seem to formalize this approach. Mr. Healey’s team clarified that under the updated regulations, rheumatoid arthritis patients will maintain their treatment authorizations for at least three months after shifting to a new insurer.

By standardizing and limiting prior authorization, the administration argues that access to care will improve and health care costs will decrease due to lower administrative burdens on hospitals and providers. The Affordable Care Quality Council noted that the national healthcare industry spent approximately $1.3 billion on administrative costs related to prior authorization in 2023, marking a 30% increase from the year prior.

On the other hand, some analyses suggest that prior authorization serves as a necessary tool for controlling health spending. A 2023 report by Milliman, commissioned by the Massachusetts Health Plans Association, claims that eliminating prior authorization could raise health spending by $600 to $1,500 per member each year.

“Prior authorization isn’t just red tape; it’s a critical affordability measure that promotes evidence-based care, limits unnecessary services, and shields patients from excess costs,” stated Lora Pellegrini, CEO of the association.

Regardless of the potential financial implications, this change could genuinely impact patients who often find themselves caught in a complex middle ground.

During Mr. Healey’s press conference, a patient named Melissa recounted her struggle to obtain crucial medication after being diagnosed with a serious autoimmune neurological condition. Her illness caused severe weight loss, cognitive issues, hormonal disruptions, tissue damage, and halted many basic bodily functions. She had to wait three months for insurance approval, during which her condition deteriorated. She couldn’t hide her tears as she spoke about the lasting effects on her body and quality of life during the wait.

“For patients dealing with neurological conditions like mine, three months feels more like three years. Why should I have to endure that delay and suffering?” she expressed.

Dr. Paul Hattis, a senior fellow at the Roan Institute, pointed out that prior authorization wouldn’t be fully eliminated, expressing skepticism about how much reducing these specific authorizations would lower costs or lessen administrative work. Still, he acknowledged that easing delays in care would clearly benefit consumers.

Mr. Healey’s newly formed working group will also create strategies aimed at enhancing health care affordability.

Members of this group will comprise representatives from various industry organizations and state government agencies, such as the Massachusetts Health and Hospital Association, the Massachusetts Medical Association, and other health-focused groups. Business associations like the Massachusetts Retailers Association and the Massachusetts Business Roundtable will also participate.

Mr. Healey expressed hope that the group could offer some recommendations by June.

A previous task force aimed at addressing health care issues yielded only limited success. The Provider Price Variability Group, set up in 2016, looked into the differences in reimbursements that health systems receive for the same services, generating a report but little change.

The Health Policy Commission, Massachusetts’s health care watchdog agency, has spent over ten years analyzing and recommending legislative reforms to control ever-rising health care spending, achieving mixed results.

Though this new group seems primarily focused on reform, Dr. Hattis is hopeful that their efforts will lead to meaningful changes.

“This time, it’s got to be different,” Dr. Hattis remarked. “The challenges regarding affordability are immense right now and only getting larger. I can’t see how our Congress could sit back and not take action on behalf of the commonwealth.”